Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 9
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience Trier par ordre croissant | Purpose |
---|---|---|---|---|---|---|
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE | 2017 | Platelets | View Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Health care providers | Clinical research |
The Stem Cell Club: a model for unrelated stem cell donor recruitment | Fingrut W, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang YG, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H | 2017 | Transfusion | View The Stem Cell Club: a model for unrelated stem cell donor recruitment | Health care providers | New or improved product or process |
Transfusion reactions: prevention, diagnosis, and treatment | Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A | 2016 | Lancet | View Transfusion reactions: prevention, diagnosis, and treatment | Health care providers | Clinical research |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Diego System: Anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Wra | Health care providers | Benchmarking and standard setting |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S | 2019 | JAMA Intern Med | View Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Health care providers | Benchmarking and standard setting |
Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Guide de la pratique transfusionnelle | View Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services | Bodnar M, Bienz M, Clarke G | 2022 | Blood.ca website | View FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services | Health care providers | New or improved product or process |
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Iorio A, Königs C, Reding MT, Rotellini D, Skinner MW, Mancuso ME, Berntorp E | 2023 | Haemophilia | View Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Health care providers | Clinical research |
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, Delaney M, Goel R, Hendrickson JE, Keir A, Landry D, La Rocca U, Lemyre B, Maier RF, Muniz-Diaz E, Nahirniak S, New HV, Pavenski K, Dos Santos MCP, Ramsey G, Shehata N, International Collaboration for Transfusion Medicine Guidelines | 2022 | Brit J Haem | View International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Health care providers | Benchmarking and standard setting |
A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins | Kelton JG, Warkentin TE, Moore JC, Arnold DM, Nazi I, Arepally GM, Roach JM, Fier I | 2012 | J Thromb Haemost | View A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins | Health care providers | Clinical research |
Autoimmune heparin-induced thrombocytopenia | Greinacher A, Selleng K, Warkentin TE | 2017 | J Thromb Haemost | View Autoimmune heparin-induced thrombocytopenia | Health care providers | Clinical research |
Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C | 2012 | Transfusion | View Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Health care providers | New or improved product or process |
How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey | Patriquin CJ, Clark WF, Pavenski K, Arnold DM, Rock G, Foley SR, for the Canadian Apheresis Group | 2016 | J Clin Apher | View How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey | Health care providers | Clinical research |
Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Patel SN, Gubbay JB, Bastien N, Booth T, Charest H, Chernesky M, Couillard M, Drews S, Garceau R, Gubbay J, Guercio S, Fearon M, Fonseca K, Hatchette T, Horsman G, Larke B, Li Y, Majury A, Ouellette O, Petric M, Ratnam S, Sevenhuysen C, Van Caeseele P | 2012 | National Collaborating Centre for Infectious Diseases: Evidence Reviews on Pandemic H1N1 | View Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Health care providers | Other |
Les composants sanguins | Clarke G | 2017 | Guide de la pratique transfusionnelle | View Les composants sanguins | Health care providers | Benchmarking and standard setting |
Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis | Chai-Adisaksopha C, Alexander PE, Guyatt G, Crowther MA, Heddle NM, Devereaux PJ, Ellis M, Roxby D, Sessler DI, Eikelboom JW | 2017 | Vox Sang | View Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis | Health care providers | Clinical research |
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Christou G, Iyengar A, Shorr R, Tinmouth A, Saidenberg E, Maze D, Tay J, Bredeson C, Allan DS | 2016 | Transfusion | View Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Health care providers | Clinical research |
Residual Risk of HIV, HCV and HBV in Canada | O'Brien SF, Yi Q-L, Fan W, Scalia V, Goldman M, Fearon MA | 2017 | Transfus Apher Sci | View Residual Risk of HIV, HCV and HBV in Canada | Health care providers | Clinical research |
The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Lagerquist O, Poseluzny D, Werstiuk G, Slomp J, Maier M, Nahirniak S, Clarke G | 2017 | ISBT Sci Ser | View The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Health care providers | Ethical, legal and social implications research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Jenkins C | 2019 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Kell System: Anti-Jsa | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Kell System: Anti-Jsa | Health care providers | Benchmarking and standard setting |
Pour un bon équilibre : protection des données dan les travaux de recherche | Ward R | 2019 | Blood.ca website | View Pour un bon équilibre : protection des données dan les travaux de recherche | Health care providers | Other |
Système Lutheran : l’anticorps anti-Lua | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Lutheran : l’anticorps anti-Lua | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Li N, Chiang F, Down DG, Heddle NM | 2021 | Oper Res Health Care | View A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Health care providers | New or improved product or process |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Iba T, Levy JH, Warkentin TE | 2022 | Crit Care Med | View Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Benchmarking and standard setting |
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure | Candeliere J, Kirkham AM, Shorr R, Morris G, Berardi P, Seftel MD, Allan DS | 2022 | Cell Ther Transplant | View Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure | Health care providers | New or improved product or process |
Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Health care providers | Benchmarking and standard setting |
FAQ : plasma traité au solvant-détergent (Octaplasma) | Mack J, Gordon I, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ : plasma traité au solvant-détergent (Octaplasma) | Health care providers | New or improved product or process |
Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Patterson S, Sandercock N, Verhovsek M | 2022 | Am J Hematol | View Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2023 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Tseng E, Crowther MA, Hillis CM | 2016 | CMAJ | View Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Health care providers | Clinical research |
HDFN and Perinatal Immune Thrombocytopenia | Webert K, Hume H, Revised by Clarke G and Hannon J. | 2015 | Clinical Guide to Transfusion | View HDFN and Perinatal Immune Thrombocytopenia | Health care providers | Other |
IgA deficiency | Goldman M | 2018 | Blood.ca website | View IgA deficiency | Health care providers | Benchmarking and standard setting |
Investigation of acute transfusion reactions | Webert K, Heddle N | 2017 | Practical Transfusion Medicine, 5th Edition | View Investigation of acute transfusion reactions | Health care providers | Benchmarking and standard setting |
Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Zeller MP, Arnold DM, Al Habsi K, Cserti-Gazdewich C, Delage G, Lebrun A, Heddle NM | 2017 | Transfusion | View Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Health care providers | Clinical research |
Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Olan P | 2012 | Acta Obstet Gyn Scan | View Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Health care providers | Clinical research |
Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation | Wiebe C, Nickerson P | 2013 | Curr Opin Organ Transplant | View Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation | Health care providers | Clinical research |
Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?†| Vuong J, Qiu Y, La M, Clarke G, Swinkels DW, Cembrowski G | 2014 | Am J Hematol | View Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?†| Health care providers | Clinical research |
Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia | Jansen AJG, Peng J, Zhao H-G, Hou M, Ni H | 2015 | Am J Hematol | View Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia | Health care providers | Clinical research |